Overexpression of Myb has been detected in both acute myeloid leukemia and non-Hodgkin lymphoma (85, 86), while Tmem206 and Cited2 overexpression was detected in colon cancer and prostate cancer, respectively. Here, PACC1 is linked to prostate cancer.